What's breaking now, across thousands of outlets.
(RTTNews) - On Sunday, Freenome, Inc. (FRNM) said it will present new clinical validation data for an updated version of its SimpleScreen colorectal cancer (CRC) blood-based screening test at the American College of Gastroenterology (ACG) 2026 Annual Meeting in Nashville.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
The Pope says the small growth is ‘well-contained’ and was spotted early; recovery from surgery to take about a week, Vatican says
The Pope says the small growth is ‘well-contained’ and was spotted early; recovery from surgery to take about a week, Vatican says
Envisioned as a platform for senior citizens and those in their 50s, Young at Heart hopes to bring people together to rediscover life’s little pleasures — new friendships, new learning experiences…
The 71-year-old Pope said the growth in his lung was ‘well contained’ and spotted early.
Health-e News OP-ED | Menstrual health is about more than giving girls menstrual products Seventy-five percent of girl learners surveyed in I_Menstruate Movement’s Bleeding in Silence: Barriers to…
AstraZeneca has announced a total investment of more than US$100 million in its Young Health Programme (YHP) between 2010 and 2030, supporting its commitment to advancing health equity in more than 60…
